Since the introduction of lithium ions in the acute treatment and in the pr
ophylaxis of bipolar disorders the antiepileptic drugs valproate and carbam
azepine have been in use for several years as mood stabilizers. In a number
of open and controlled clinical studies predictors of response for the sin
gle drugs were investigated. These studies indicated that valproate was a p
redictor of good response in mixed (dysphoric) mania and bipolar rapid cycl
ing. Moreover, valproate has a better response than lithium in secondary ma
nia (organic origin) and atypical mania (episode sequence: depression - man
ia - euthymia rather than mania - depression - euthymia). The preferential
efficacy in the spectrum of bipolar disorders of the new antiepileptic drug
s lamotrigine and gabapentin must be analysed in more detail in future stud
ies.